“For decades, the diabetes world has focused on lowering sugar, not on treating the root cause of the disease nor on stopping its progression” said Dr. Dror Chevion, co-founder and CEO of Concenter ...
Thermo Fisher Scientific is acquiring Clario for roughly $8.9 billion, a major move to boost its clinical research services.
Orphan Drug Designation applies to approximately 50,000 Patients who predominantly suffer from severe chronic pain due to ...
Oncolytics also recently expanded its Scientific Advisory Board with globally recognized experts from Memorial Sloan Kettering Cancer Center and MD Anderson Cancer Center, positioning the company for ...
The U.S. Food and Drug Administration and the European Medicines Agency jointly issued principles for safe and responsible ...
An inconsistent boom-and-bust cycle funding environment for early-stage biotech innovations and burdensome regulation ...
Eikon Therapeutics, Inc. eyes IPO to fund EIK1001 oncology pipeline; early Phase 2 data show 60% response rate. Click for ...
Beyond Air (XAIR) stock surged 150% as XTL acquired 85% of NeuroNOS for $32.5M. Trading volume jumped 363% on autism treatment platform deal.
Title: Gemini restores normal innate immune response in CKD patients Presenter: Robin Marsden, Senior Vice President of Biology, Revelation Biosciences Date/Time: Sunday, March 29, 2026 5:30 p.m.
Haider Warraich was once the only cardiologist for more than 150,000 people in a rural county. Now he’s running an ARPA-H ...
The firm is focused on helping pharma characterize response and resistance to their drugs, with the hope of getting a companion diagnostic approval.
During Fast Company and Johns Hopkins University’s World Changing Ideas Summit last November, we asked leaders what are the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback